CP
CLEARPharma
ShopPre-OrdersSale
CP
CLEARPharma

Your source for pharmaceutical-grade performance compounds. Lab-tested, quality assured.

ClearPharmacy@proton.me

Shop

  • Shop All
  • On Sale
  • Pre-Orders
  • Wishlist

Support

  • Track Your Order
  • FAQ
  • Contact Us
  • Request a Product
  • Terms & Shipping Policy
  • Privacy

Trust & Learn

  • Fund Testing / COAs
  • Compound Education
  • Calculators & Tools
  • Blog

© 2026 Clear Pharma. All rights reserved.

Home
Shop
Cart
Wishlist
Account

Your Cart

Your cart is empty.

Browse products
All compounds

Nandrolone (NPP / Deca-Durabolin)

Oils

Nandrolone is a 19-nortestosterone derivative available as Nandrolone Phenylpropionate (NPP, short ester) and Nandrolone Decanoate (Deca-Durabolin, long ester). It is one of the most popular anabolic steroids for mass building, prized for its strong anabolic effects, joint-supportive collagen synthesis properties, and relatively mild androgenic profile.

Half-life: NPP: 2-4 days; Deca: 12-16 daysDose: NPP: 100mg EOD (beginner), 100-150mg EOD (intermediate), 150-200mg EOD (advanced). Deca: 200-300mg/week (beginner), 300-500mg/week (intermediate), 500-700mg/week (advanced)PCT Required

Notes

ALWAYS run nandrolone with a testosterone base at equal or higher dose. The classic recommendation is to keep testosterone at least equal to nandrolone dosage to avoid "Deca Dick." Having cabergoline (0.25-0.5mg 2x/week as needed) on hand for prolactin management is essential. NPP is strongly preferred over Deca for first-time nandrolone users because its shorter half-life allows faster clearance if side effects become problematic. Nandrolone is one of the most suppressive compounds and PCT recovery is notoriously difficult after long Deca cycles.

Nandrolone binds to the androgen receptor with high affinity and exhibits a notably higher anabolic-to-androgenic ratio (125:37) compared to testosterone (100:100). Unlike testosterone, nandrolone is reduced by 5-alpha reductase to dihydronandrolone (DHN), which is a weaker androgen than DHT, explaining the reduced androgenic side effects in skin, prostate, and hair. However, nandrolone also binds to progesterone receptors at approximately 20% the affinity of progesterone itself, contributing to progestogenic side effects. It potently stimulates collagen synthesis and bone mineral content through direct action on osteoblasts and fibroblasts, making it therapeutically relevant for joint health. Nandrolone also increases IGF-1 expression in muscle tissue more than equivalent doses of testosterone.

NPP (phenylpropionate ester): Rapidly absorbed from the IM depot, reaching peak levels within 24-48 hours with a half-life of 2-4 days. Allows for faster dose adjustments and shorter overall cycle clearance. Deca (decanoate ester): Slowly absorbed with peak levels at 3-6 days post-injection and a terminal half-life of 12-16 days. Reaches steady state after approximately 8-10 weeks. Nandrolone metabolites (19-norandrosterone and 19-noretiocholanolone) are exceptionally persistent in urine, detectable up to 18 months after the last injection of Deca. Hepatic metabolism occurs through reduction, oxidation, and conjugation pathways.

Typical Dose

NPP: 100mg EOD (beginner), 100-150mg EOD (intermediate), 150-200mg EOD (advanced). Deca: 200-300mg/week (beginner), 300-500mg/week (intermediate), 500-700mg/week (advanced)

Frequency

NPP: Every other day; Deca: 1-2x per week

Administration

Intramuscular injection

Half-Life

NPP: 2-4 days; Deca: 12-16 days

  • ✓Exceptional lean muscle mass gains with moderate water retention
  • ✓Significantly enhanced collagen synthesis and joint lubrication (therapeutic for joint pain)
  • ✓Strong nitrogen retention and protein synthesis (higher anabolic rating than testosterone)
  • ✓Improved bone mineral density
  • ✓Enhanced IGF-1 output
  • ✓Relatively low androgenic side effects compared to testosterone
  • ✓Increased red blood cell production
  • ✓Synergistic with testosterone for mass-building cycles
  • ⚠Progestogenic activity leading to potential gynecomastia (even without high estrogen)
  • ⚠"Deca Dick" - erectile dysfunction and reduced libido from elevated prolactin and progesterone
  • ⚠Severe HPTA suppression that can be prolonged (especially with Deca ester)
  • ⚠Water retention and bloating at higher doses
  • ⚠Potential for increased prolactin levels requiring cabergoline or pramipexole
  • ⚠Negative impact on lipid panel (particularly HDL suppression)
  • ⚠Long detection time (18 months for Deca) problematic for tested athletes
  • ⚠Potential for anxiety and mood disturbances ("Deca anxiety") in sensitive individuals

Contraindications

  • 🚫History of prolactin-sensitive conditions
  • 🚫Pre-existing cardiovascular disease
  • 🚫Prostate cancer or BPH
  • 🚫Severe renal impairment (nandrolone can exacerbate)
  • 🚫Liver disease
  • 🚫Pregnancy
  • 🚫History of depression or anxiety (nandrolone can worsen)
  • 🚫Individuals who cannot commit to prolonged PCT recovery
Total Testosterone (ensure base is adequate; target above nandrolone dose)Estradiol (Sensitive/LC-MS)Prolactin (critical; target: under 20 ng/mL, elevated levels cause sexual dysfunction)ProgesteroneLipid Panel (HDL will likely be significantly suppressed)Hematocrit and HemoglobinLiver enzymes (AST, ALT)Kidney function (BUN, Creatinine - nandrolone can affect kidney markers)CBCLH/FSH (will be completely suppressed)
Week 1-2 (NPP) / Week 1-4 (Deca): Initial loading phase. NPP users may feel joint relief and improved recovery within 1-2 weeks. Deca users need patience as the long ester takes 3-4 weeks to saturate. Week 3-6 (NPP) / Week 5-8 (Deca): Full effects manifest. Significant increases in muscle fullness, strength, and recovery. Joints feel noticeably better. Monitor for prolactin-related sides (nipple sensitivity, reduced libido). Week 7-10 (NPP) / Week 9-14 (Deca): Peak cycle phase. Maximum muscle and strength gains. Weight gain of 12-20+ lbs is typical on a bulk. Water retention should be managed. Mid-cycle bloodwork recommended to check prolactin and lipids. Week 11-12 (NPP) / Week 15-16 (Deca): Final weeks. Taper considerations for Deca due to extremely long clearance. NPP can be discontinued and PCT started within 1 week. Post-cycle: NPP allows PCT to begin 5-7 days after last injection. Deca requires waiting 3-4 weeks minimum before starting PCT.
PCT Required

NPP: Begin PCT 5-7 days after last injection. Deca: Begin PCT 21-28 days after last injection due to the long decanoate ester. Bridge with testosterone propionate during the waiting period if needed. PCT protocol: Nolvadex 20mg/day for 8 weeks (longer PCT than testosterone-only cycles due to severe suppression), or Clomid 50mg/day for 4 weeks then 25mg/day for 4 weeks. HCG during cycle is STRONGLY recommended (500IU 2x/week) to maintain testicular function. Some users run hCG at 1000-1500IU EOD for 2-3 weeks before starting SERMs. Bloodwork at 6 and 12 weeks post-PCT to ensure full HPTA recovery.

  • 1.NPP is strongly preferred for a first nandrolone experience; if you get bad sides you want them to clear fast
  • 2.Always run testosterone at least equal to your nandrolone dose to prevent "Deca Dick"
  • 3.Keep cabergoline on hand (0.25mg 2x/week) and dose it only when prolactin symptoms appear or bloodwork shows elevation above 20 ng/mL
  • 4.Vitamin B6 (P-5-P form, 100-200mg/day) can help mildly manage prolactin before resorting to cabergoline
  • 5.Do not run nandrolone without hCG during cycle; the HPTA suppression is severe and prolonged recovery without it is common
  • 6.Joint pain relief is one of the most valued effects; low-dose nandrolone (100-150mg/week) is used therapeutically by some for this purpose alone
Testosterone CypionateTestosterone EnanthateDianabol (Methandrostenolone)Anadrol (Oxymetholone)Anavar (Oxandrolone)
  1. [1]Kuhn CM. Anabolic steroids. Recent Prog Horm Res. 2002;57:411-434.
  2. [2]Toth M, Zakar T. Relative binding affinities of testosterone, 19-nortestosterone and their 5-alpha reduced derivatives to the androgen receptor. J Steroid Biochem. 1982;17(6):653-660.
  3. [3]Van der Vies J. Pharmacokinetics of nandrolone decanoate. Acta Endocrinol. 1985.
  4. [4]Bagchus WM, et al. Pharmacokinetics of nandrolone decanoate. Acta Endocrinol. 2005.